Literature DB >> 17520735

Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects.

Gabriele A Krombach1, Christa Hahn, Maren Tomars, Arno Buecker, Armin Grawe, Rolf W Günther, Harald P Kühl.   

Abstract

In cardiac amyloidosis an interstitial deposition of amyloid fibrils causes concentric thickening of the atrial and ventricular walls. We describe the results of tissue characterization of the myocardium by T1 quantification and MRI findings in a patient with cardiac amyloidosis. The T1 time of the myocardium was elevated compared to that in individuals without amyloidosis. The T1 time of the myocardium was 1387 +/- 63 msec (mean value obtained from four measurements +/- standard deviation [SD]) in the patient with cardiac amyloidosis, while the reference value obtained from the myocardium of 10 individuals without known myocardial disease was 1083 +/- 33 msec (mean value +/- SD). In combination with other MR findings suggestive of amyloidosis, such as homogeneous thickening of the ventricular and atrial walls, thickening of the valve leaflets, restrictive filling pattern, and reduction of systolic function, T1 quantification may increase diagnostic confidence. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520735     DOI: 10.1002/jmri.20917

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  16 in total

1.  Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis.

Authors:  Ralf Wassmuth; Hassan Abdel-Aty; Steffen Bohl; Jeanette Schulz-Menger
Journal:  Eur Radiol       Date:  2011-03-29       Impact factor: 5.315

2.  T1 mapping and magnetic resonance elastography: potential new techniques for quantification of parenchymal changes in hepatic amyloidosis.

Authors:  Elif Peker; Ayşe Erden
Journal:  Diagn Interv Radiol       Date:  2017 Nov-Dec       Impact factor: 2.630

3.  Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 1: Common phenotypes.

Authors:  Shaunagh McDermott; Ailbhe C O'Neill; Carole A Ridge; Jonathan D Dodd
Journal:  World J Cardiol       Date:  2012-04-26

Review 4.  CT and MRI evaluation of cardiac complications in patients with hematologic diseases: a pictorial review.

Authors:  Tae Yun Kim; Jung Im Jung; Yoo Jin Kim; Hwan Wook Kim; Hae Giu Lee
Journal:  Int J Cardiovasc Imaging       Date:  2015-02-05       Impact factor: 2.357

5.  [MRI in cardiac sarcoidosis and amyloidosis].

Authors:  K U Bauner; B Wintersperger
Journal:  Radiologe       Date:  2013-01       Impact factor: 0.635

6.  Cardiac MRI in infiltrative disorders: a concise review.

Authors:  Neelima Penugonda
Journal:  Curr Cardiol Rev       Date:  2010-05

7.  Cardiac Amyloidosis Diagnosis with Magnetic Resonance Imaging: A Case Report.

Authors:  Meidi El Issa; Malik El Issa; Besma Sidia
Journal:  Cureus       Date:  2018-03-15

Review 8.  Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.

Authors:  Joel N Buxbaum; Frederick L Ruberg
Journal:  Genet Med       Date:  2017-01-19       Impact factor: 8.822

9.  Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance.

Authors:  Vanessa M Ferreira; Stefan K Piechnik; Erica Dall'Armellina; Theodoros D Karamitsos; Jane M Francis; Robin P Choudhury; Matthias G Friedrich; Matthew D Robson; Stefan Neubauer
Journal:  J Cardiovasc Magn Reson       Date:  2012-06-21       Impact factor: 5.364

10.  Multi-parametric MRI as an indirect evaluation tool of the mechanical properties of in-vitro cardiac tissues.

Authors:  Delphine Périé; Nagib Dahdah; Anthony Foudis; Daniel Curnier
Journal:  BMC Cardiovasc Disord       Date:  2013-03-27       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.